 SEATTLE SAN FRANCISCO--BUSINESS WIRE--NanoString Technologies, Inc. NASDAQ: NSTG, a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy PICI announced today that they are collaborating on an expansive molecular characterization project for cellular therapies. The collaboration will define the characteristics that make a cell therapy effective, providing a standardized approach to developing CAR-T regimens tha 